Jinghua Pharmaceutical Group Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Jinghua Pharmaceutical Group has a total shareholder equity of CN¥2.9B and total debt of CN¥25.9M, which brings its debt-to-equity ratio to 0.9%. Its total assets and total liabilities are CN¥3.2B and CN¥319.6M respectively. Jinghua Pharmaceutical Group's EBIT is CN¥261.8M making its interest coverage ratio -7.1. It has cash and short-term investments of CN¥1.2B.
Belangrijke informatie
0.9%
Verhouding schuld/eigen vermogen
CN¥25.92m
Schuld
| Rente dekkingsratio | -7.1x |
| Contant | CN¥1.23b |
| Aandelen | CN¥2.87b |
| Totaal verplichtingen | CN¥319.61m |
| Totaal activa | CN¥3.19b |
Recente financiële gezondheidsupdates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: 002349's short term assets (CN¥2.0B) exceed its short term liabilities (CN¥301.7M).
Langlopende schulden: 002349's short term assets (CN¥2.0B) exceed its long term liabilities (CN¥17.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 002349 has more cash than its total debt.
Schuld verminderen: 002349's debt to equity ratio has reduced from 20.7% to 0.9% over the past 5 years.
Schuldendekking: 002349's debt is well covered by operating cash flow (1112.7%).
Rentedekking: 002349 earns more interest than it pays, so coverage of interest payments is not a concern.